Soleus Capital Management, L.P. - MIRUM PHARMACEUTICALS INC ownership

MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 103 filers reported holding MIRUM PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.6%.

Quarter-by-quarter ownership
Soleus Capital Management, L.P. ownership history of MIRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$3,254,800
-28.5%
103,000
-41.5%
0.30%
-40.7%
Q2 2023$4,553,120
-21.7%
176,000
-27.3%
0.51%
-15.9%
Q1 2023$5,812,840
+104.0%
242,000
+78.4%
0.60%
+55.6%
Q3 2022$2,849,000
-25.3%
135,618
-30.8%
0.39%
-35.0%
Q2 2022$3,815,000
-49.6%
196,018
-42.9%
0.60%
-39.0%
Q1 2022$7,564,000343,5000.98%
Other shareholders
MIRUM PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 3,566,912$62,278,0004.80%
RiverVest Venture Management LLC 1,921,118$33,543,0003.68%
Burrage Capital Management LLC 161,628$2,822,0002.15%
AIGH Capital Management LLC 274,583$4,794,0001.95%
NEA Management Company, LLC 4,187,801$73,119,0001.93%
Novo Holdings A/S 2,445,147$42,692,0001.83%
Sio Capital Management, LLC 494,743$8,638,0001.77%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,448,912$60,218,0001.19%
Rock Springs Capital Management LP 1,496,525$26,129,0000.55%
Prosight Management, LP 60,250$1,052,0000.49%
View complete list of MIRUM PHARMACEUTICALS INC shareholders